There is a region on the spike protein of SARS-2 that is sometimes used by the immune system as an epitope for antibodies that is almost identical to the region of the platelets that triggers their activation. This means that there are antibodies that were produced against the spike protein, but can bind to platelets and activate their aggregation.
This explains it. Thank you.
>There is a region on the spike protein of SARS-2 that is sometimes used by the immune system as an epitope for antibodies that is almost identical to the region of the platelets that triggers their activation. This means that there are antibodies that were produced against the spike protein, but can bind to platelets and activate their aggregation.
This explains it. Thank you.
(post is archived)